POLYMED.BOPOLYMED.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +24.92% | +16.60% | +4.79% | +5.68% | +16.37% |
| Gross Profit Growth | +25.34% | +19.16% | +7.59% | +7.21% | -30.16% |
| EBITDA Growth | +23.51% | +22.77% | +3.42% | +30.39% | +20.54% |
| Operating Income Growth | +28.01% | +0.00% | +24.07% | -23.44% | -26.08% |
| Net Income Growth | +31.09% | +34.34% | +25.72% | +5.01% | -16.78% |
| EPS Growth | +25.07% | +25.28% | +19.20% | +0.55% | -17.45% |
| EPS Diluted Growth | +25.26% | +25.28% | +18.94% | +0.55% | -17.57% |
| Weighted Average Shares Growth | +4.65% | +7.28% | +5.70% | +4.43% | +0.82% |
| Weighted Average Shares Diluted Growth | +4.65% | +7.23% | +5.70% | +4.43% | +0.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +29.68% | +0.00% | +29.68% | +0.00% |
| Inventory Growth | +0.00% | +29.20% | +0.00% | +28.42% | +0.00% |
| Asset Growth | +0.00% | +71.76% | +0.00% | +17.53% | +0.00% |
| Book Value per Share Growth | +85.05% | +75.37% | +77.98% | +7.85% | +0.00% |
| Debt Growth | +0.00% | +3.50% | +0.00% | +49.14% | +0.00% |
| R&D Expense Growth | -15.18% | +109.67% | +62.13% | +51.18% | +49.19% |
| SG&A Expenses Growth | +28.96% | +11.51% | +6.11% | -100.00% | -100.00% |